Streamline the Experience of Enhanced Imaging
43% of women opt out of the breast care pathway when recommended for diagnostic breast follow-up.
- According to The Breast Journal1
The stressors of time, cost, and lack of comfort associated with the breast care pathway have led to a staggering number of women not getting the breast care they need. Let’s help you reach that 43%.
GE Healthcare’s contrast-enhanced mammography (CEM) system offers an excellent alternative for breast cancer detection. For your patients, CEM is an affordable, comfortable, and fast diagnostic option that allows them to continue their critical breast care. For your facility, CEM allows you to provide expanded and equitable patient access.
In addition to increasing patient access, our CEM offering, SenoBright™ HD, boasts high levels of sensitivity and specificity, for low false positives and unnecessary callbacks. With the introduction of Serena Bright™, clinicians can now perform biopsies using the same image guidance as the lesion identification, all on the same mammography system.
We believe personalized breast care means equal access to advanced imaging for all women. With CEM and CEM biopsy available through SenoBright and Serena Bright, you can ensure exceptional breast care to more women in your community.
The stressors of time, cost, and lack of comfort associated with the breast care pathway have led to a staggering number of women not getting the breast care they need. Let’s help you reach that 43%.
GE Healthcare’s contrast-enhanced mammography (CEM) system offers an excellent alternative for breast cancer detection. For your patients, CEM is an affordable, comfortable, and fast diagnostic option that allows them to continue their critical breast care. For your facility, CEM allows you to provide expanded and equitable patient access.
In addition to increasing patient access, our CEM offering, SenoBright™ HD, boasts high levels of sensitivity and specificity, for low false positives and unnecessary callbacks. With the introduction of Serena Bright™, clinicians can now perform biopsies using the same image guidance as the lesion identification, all on the same mammography system.
We believe personalized breast care means equal access to advanced imaging for all women. With CEM and CEM biopsy available through SenoBright and Serena Bright, you can ensure exceptional breast care to more women in your community.
In the end, saving your patients time and money saves you time and money.
CEM with SenoBright and Serena Bright can be introduced to many types of facilities. These solutions can work to complement MRI programs currently in place or, because they utilize the same Pristina gantry, can be easily implemented as a new offering in facilities that do not have MRI.
The reduced cost for patients is passed onto providers, who can spend less time and money writing off or chasing unpaid bills. Your facility can enjoy increased accessibility, operational efficiency, and revenue while also enhancing patient satisfaction with more comfortable exams, consistent specialists, and the reduction of anxiety-producing wait times and financial burdens.
The reduced cost for patients is passed onto providers, who can spend less time and money writing off or chasing unpaid bills. Your facility can enjoy increased accessibility, operational efficiency, and revenue while also enhancing patient satisfaction with more comfortable exams, consistent specialists, and the reduction of anxiety-producing wait times and financial burdens.
Sources
1. Two out of three patients prefer CEM experience over breast MRI exam and biopsy; Mosier, A., Gupta, E., Ataya, D., Bhatt, K. and Rim, A. (2017), Low Compliance in a Health-Conscience Spending Era Likely Helps Obviates the Need for 6 month BI-RADS 3 Breast MRI Follow-up After 1 year. Breast J, 23: 504-508. https://doi.org/10.1111/tbj.127842. Data on file CESM Biopsy vs MR Biposy Cost Analysis . GE Healthcare